Jonathan Root spent nine years in clinical practice before joining USVP in 1995 as an Ewing Marion Kauffman Fellow in venture capital. He became a general partner in 1997. Before USVP, Dr. Root was on the faculty and clinical staff at The New York Hospital-Cornell Medical Center in New York City. There he was an assistant professor of neurology and director of the neurology-neurosurgery special care unit. He is board certified in neurology. Dr. Root is currently on the boards of USVP portfolio companies of Cleave Biosciences, eFFECTOR Therapeutics, Inari Medical, Omada Health, Ribon and Route 92 Medical. Dr. Root is a former board member for the National Venture Capital Association (NVCA). He holds an A.B. in economics from Dartmouth College, an M.D. from the University of Florida College of Medicine and an M.B.A. from Columbia University.